Nammude Arogyam November 2017 | Page 41
HbA1C ]cn-tim[\
Blm-c-¯n\v ap³
]pw ]n³]p-apÅ cà-
¯nse ¥qt¡m-knsâ
Af-hn\v ]pdta
{]tal tcmK\nb-{´-
W-¯nsâ \nÀW-b-
¯n hfsc {]m[m
\yw AÀln-¡p¶ Hcp
]cn-tim[\bmWv
HbA1C. efn-X-ambn
]d-ªm cà-¯nse
¥qt¡m-knsâ ]n¶n«
aq¶p amks¯ Hcp
icm-icn BWv
HbA1C. HbA1C 5.5%
 Xmsg-bm-sW-¦nÂ
Hcp hyàn¡v {]ta-l-
anà F¶v \ap¡v
Ønco-I-cn-¡mw. A©c
apXÂ Bdv iX-am\w
hsc (5.5% apXÂ 6%)
{]tal ]qÀÆ AhØ
sb kqNn-¸n-¡p-¶p.
Hcp {]tal tcmKn-bnÂ
{]talw \nb-{´W
hnt[-b-am-sW¶v Icp-X-
W-sa-¦n HbA1C 6.5
- 7.0% \v AIw Bbn-
cn-¡-Ww. {]tal
tcmKn-I-fnse asäm-cp
{]Xn-`m-k-amb cà-¥q-
t¡m-knsâ AØn-c-X-
sbbpw (ss¥knanIv
thcn-b-_n-en-än) k¦oÀ
W-X-I-fpsS Hcp
{][m\ Imc-W-am-
bmWv IW-¡m-¡p-¶-
Xv. Nne {]tal tcmKn-
I-fn {]tXy-In¨pw
{]mbw IqSn-b {]tal
tcmKn-I-fn cà-
¯nse ¥qt¡m-knsâ
\ne henb tXmXnÂ
hyXn-N-en-¡p-¶-Xmbn
Iïp-h-cm-dp-ïv. C¯-c-
¯nse Gä-¡p-d-¨n-ep-
IÄ, AXm-bXv cà-
¯nse ¥qt¡m-knsâ
\ne Aan-X-ambn IqSp-
Ibpw Ipd-bp-Ibpw
sN¿p-¶-Xv, ]e
{]tal tcmK-k-¦oÀW-
X-I-fp-tSbpw Xo{hX
Iq«p-¶-Xmbn ImW-s¸-
Sp-¶p. {]mbw IqSnb
{]tal tcmKn-I-fnÂ
Dïm-Ip¶ cà
¥qt¡m-knsâ Aan-X-
amb Ipd-b (hypo
glycemia) ]e-t¸mgpw
lrt{ZmK km²y-Xsb
Iq«p-¶-Xm-bpw, s]s«-
¶pÅ ac-W-¯n\v
Imc-W-am-Ip-¶-Xmbpw
]T-\-§Ä Ønco-I-cn-
¡p-¶p. AXp-sImïv
{]mbw IqSnb {]tal
tcmKn-I-fn HbA1C
7.0% Â Xmsg \nÀ
¯m³ iTn¡m-Xn-cn-¡p-
¶-Xmhpw D¯-aw.
Fs´-¶m C¯-c-
¯n ¥qt¡mkv Ipd-
bv¡p¶ {ia-¯n-\nsS
Aan-X-ambn ¥qt¡mkv
Ipd-bp-Ibpw AXv
Poh\v Xs¶ B]-¯m-
Ip-Ibpw sNbvtX-¡mw.
\½p-sS B-tcm-Kyw | 2017 \hw_À
41